Blog: Jul 2019

Atlantic Discovery Talk

30 July 2019

Atlantic Discovery came to tell the story of their adventures - watch it now!

Research request from Kings College London

30 July 2019

Source Kings College London: "I am a third-year psychology student at King’s College London, currently assisting a PhD student, Jowinn Chew (cc'd in this email), on her research supervised by Dr Colette Hirsch and Prof Rona Moss-Morris from the Health Psychology Department. The research is focusing on identifying the cognitive mechanisms which underpin and maintain anxiety surrounding illness uncertainty within MS.

New Pilates class for people with MS in Wokingham

30 July 2019

Pilates Plans: Alison Newton, MS MS Specialist Occupational Therapist, is hoping to start up a Pilates class for people in the Wokingham area with early stages of MS. (likely to be either Westmead Day Centre in Wokingham or Shinfield community centre.)

No Yoga until Monday 19th August

30 July 2019

Uddhava is taking a break from his classes

There will be no yoga at the Centre for the next 2 weeks. Classes resume as usual on Monday 19th August. For more information about our yoga classes click here.

Early MS scans 'can predict long-term prognosis'

30 July 2019

Source BBC: Scans carried out when someone is first diagnosed with multiple sclerosis can predict their long-term prognosis, research has shown.

MS: Drugs trial hope for multiple sclerosis patients

30 July 2019

Source BBC: Welsh patients are taking part in a drugs trial aimed at slowing late-stage multiple sclerosis progression.

EMA warns that Gilenya must not be taken during pregnancy.

30 July 2019

Source MS Trust: The European Medicines Agency (EMA) has recommended that Gilenya (fingolimod) must not be taken by pregnant women or women of childbearing age who are not using effective contraception.

This Friday 2nd August - Art Therapy at BMSTC 10.00am - 11.30am

29 July 2019

If you would be interested in attending our regular Art Therapy session at the Centre, on the first Friday of the month 10.00am to 11.30am, please email Pippa to book your place.

Phase 1 Trial of T20K, Plant Protein-derived Therapy for MS, Doses 1st Group of Healthy Men

23 July 2019

Source Multiple Sclerosis News Today: A first group of healthy volunteers in a Phase 1 trial assessing the safety and tolerability of T20K, Cyxone‘s plant protein-derived candidate for the treatment of multiple sclerosis(MS), has been dosed in a study taking place in The Netherlands, the company announced.

Phase 3 Trial of Ibudilast Planned for SPMS Patients with Inactive Disease, MediciNova Says

23 July 2019

Source Medical News Toady: A Phase 3 trial is planned to confirm the safety and efficacy of oral ibudilast (MN-166) in treating people with secondary progressive multiple sclerosis (SPMS) without relapses or those whose disease is not active, MediciNova announced.